Peer-influenced content. Sources you trust. No registration required. This is HCN.

ACP InternistWhich Decongestant When?

Dispelling Myths and Misperceptions: An Insightful Discussion on Over-the-Counter Decongestants


In a medical field filled with complex choices and decisions, selecting an effective over-the-counter decongestant might seem relatively simple. However, misinformation and misperceptions can often lead patients, and even medical professionals, astray. The following discussion sheds light on the realities of decongestant selection and usage.

Key Points:
  • Dr. Scott Selinger identifies a common misperception regarding phenylephrine, which often receives negative patient reviews as a decongestant.
  • Pseudoephedrine, although more difficult to obtain, has proven to be more effective as a decongestant.
  • The shift towards phenylephrine in over-the-counter medicines occurred due to regulations curbing methamphetamine production, not due to its efficacy as a decongestant.
  • Oxymetazoline, despite myths about rebound congestion (rhinitis medicamentosa) after three days of use, has been found to be beneficial without significant risk of sustained rebound congestion.
Additional Points:
  • A 2009 study indicated that pseudoephedrine was more effective than either phenylephrine or a placebo.
  • Phenylephrine’s extensive metabolism limits its effectiveness as a decongestant.
  • Limited studies on oxymetazoline usage demonstrated little rebound congestion and effective relief of symptoms.
Conclusion:
  • Decongestant selection can be improved by better understanding the myths and realities surrounding these medications, including the greater effectiveness of pseudoephedrine and safe usage of oxymetazoline beyond three days.

“When they started passing more regulations to cut down on methamphetamine creation in the United States, you started seeing pseudoephedrine fall out of use, and almost simultaneously this switchover to incorporating phenylephrine in all the over-the-counter cough and cold medicines as a decongestant.”

Dr. Scott Selinger
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form